{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:25:31Z","timestamp":1790281531074,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Australian Government through Cancer Australia"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1019891"],"award-info":[{"award-number":["1019891"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHMRC Career Development Fellowship","award":["1026215"],"award-info":[{"award-number":["1026215"]}]},{"name":"The University of Queensland Early Career Researcher Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pleural mesothelioma is a cancer of serosal surfaces caused by environmental exposure to asbestos. Clinical outcome remains poor and while trials of new treatments are ongoing it remains an understudied cancer. Mesothelioma cell lines can readily be grown from primary tumour and from tumour cells shed into pleural effusion with the latter representing a particularly valuable source of DNA in clinical settings, procurable without the need for additional invasive procedures. However, it is not well understood how accurately patient-derived cultured tumour cells represent the molecular characteristics of their primary tumour. We used whole-genome sequencing of primary tumour and matched cultured cells to comprehensively characterize mutations and structural alterations. Most cases had complex rearranged genomes with evidence of chromoanagenesis and rearrangements reminiscent of chromoplexy. Many of the identified driver mutations were structural, indicating that mesothelioma is often caused by structural alterations and catastrophic genomic events, rather than point mutations. Because the majority of genomic changes detected in tumours were also displayed by the genomes of cultured tumour cells, we conclude that low-passage cultured tumour cells are generally suitable for molecular characterization of mesothelioma and may be particularly useful where tissue samples with high tumour cell content are not available. However, the subclonal compositions of the cell lines did not fully recapitulate the subclonal diversity of the primary tumours. Furthermore, longitudinal acquisition of major alterations in subclonal cell populations was observed after long-term passaging. These two factors define limitations of tumour-derived cell lines as genomic substrate for clinical purposes.<\/jats:p>","DOI":"10.1093\/carcin\/bgz066","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T11:08:56Z","timestamp":1555585736000},"page":"724-734","source":"Crossref","is-referenced-by-count":25,"title":["Whole-genome sequencing of human malignant mesothelioma tumours and cell lines"],"prefix":"10.1093","volume":"40","author":[{"given":"Harald","family":"Oey","sequence":"first","affiliation":[{"name":"Diamantina Institute, Faculty of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Daniels","sequence":"additional","affiliation":[{"name":"Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Relan","sequence":"additional","affiliation":[{"name":"Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian Mun","family":"Chee","sequence":"additional","affiliation":[{"name":"Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan R","family":"Davidson","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, The Prince Charles Hospital, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A","family":"Yang","sequence":"additional","affiliation":[{"name":"Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Ellis","sequence":"additional","affiliation":[{"name":"Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology (QUT) at Translational Research Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwun M","family":"Fong","sequence":"additional","affiliation":[{"name":"Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-0845","authenticated-orcid":false,"given":"Lutz","family":"Krause","sequence":"additional","affiliation":[{"name":"Diamantina Institute, Faculty of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayleen V","family":"Bowman","sequence":"additional","affiliation":[{"name":"Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Queensland, Australia"},{"name":"Department of Thoracic Medicine, The Prince Charles Hospital, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2020071623201315600_CIT0001","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bjc.6604879","article-title":"Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study","volume":"100","author":"Rake","year":"2009","journal-title":"Br. J. Cancer"},{"key":"2020071623201315600_CIT0002","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/JOM.0b013e3181b68cef","article-title":"Risk of mesothelioma and occupational exposure to asbestos and man-made vitreous fibers: evidence from two case-control studies in Montreal, Canada","volume":"51","author":"Pintos","year":"2009","journal-title":"J. Occup. Environ. Med."},{"key":"2020071623201315600_CIT0003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajim.20780","article-title":"Case\u2013control study of pleural mesothelioma in workers with social security in Mexico","volume":"53","author":"Aguilar-Madrid","year":"2010","journal-title":"Am. J. Ind. Med."},{"key":"2020071623201315600_CIT0004"},{"key":"2020071623201315600_CIT0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bmb\/ldp047","article-title":"Malignant mesothelioma","volume":"93","author":"Rudd","year":"2010","journal-title":"Br. Med. Bull."},{"key":"2020071623201315600_CIT0006","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAT.0b013e32835bc848","article-title":"A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit","volume":"45","author":"Segal","year":"2013","journal-title":"Pathology"},{"key":"2020071623201315600_CIT0007","first-page":"991","article-title":"Comparison of features of human lung cancer cell lines and their corresponding tumors","volume":"5","author":"Wistuba","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"2020071623201315600_CIT0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.lungcan.2009.12.005","article-title":"Lung cancer cell lines: useless artifacts or invaluable tools for medical science?","volume":"68","author":"Gazdar","year":"2010","journal-title":"Lung Cancer"},{"key":"2020071623201315600_CIT0009","doi-asserted-by":"crossref","first-page":"25619","DOI":"10.18632\/oncotarget.4627","article-title":"Patient-derived cell models as preclinical tools for genome-directed targeted therapy","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"2020071623201315600_CIT0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djt007","article-title":"The clinical relevance of cancer cell lines","volume":"105","author":"Gillet","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"2020071623201315600_CIT0011","doi-asserted-by":"crossref","first-page":"e58132","DOI":"10.1371\/journal.pone.0058132","article-title":"Phenotypes and karyotypes of human malignant mesothelioma cell lines","volume":"8","author":"Relan","year":"2013","journal-title":"PLoS One"},{"key":"2020071623201315600_CIT0012","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"2020071623201315600_CIT0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)."},{"key":"2020071623201315600_CIT0014","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nmeth.2642","article-title":"IntOGen-mutations identifies cancer drivers across tumor types","volume":"10","author":"Gonzalez-Perez","year":"2013","journal-title":"Nat. Methods"},{"key":"2020071623201315600_CIT0015","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","article-title":"Mutational processes molding the genomes of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"key":"2020071623201315600_CIT0016","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"key":"2020071623201315600_CIT0017","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/gb-2009-10-11-r128","article-title":"Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays","volume":"10","author":"Popova","year":"2009","journal-title":"Genome Biol."},{"key":"2020071623201315600_CIT0018","doi-asserted-by":"crossref","first-page":"e45835","DOI":"10.1371\/journal.pone.0045835","article-title":"qpure: a tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"2020071623201315600_CIT0019","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nm.3886","article-title":"Subclonal diversification of primary breast cancer revealed by multiregion sequencing","volume":"21","author":"Yates","year":"2015","journal-title":"Nat. Med."},{"key":"2020071623201315600_CIT0020","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/nar\/gkx193","article-title":"NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types","volume":"45","author":"Lee","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020071623201315600_CIT0021","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"2020071623201315600_CIT0022","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat. Methods"},{"key":"2020071623201315600_CIT0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol."},{"key":"2020071623201315600_CIT0024","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2020071623201315600_CIT0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"2020071623201315600_CIT0026","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"2020071623201315600_CIT0027","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-014-0301-3","article-title":"Evaluation of clonal origin of malignant mesothelioma","volume":"12","author":"Comertpay","year":"2014","journal-title":"J. Transl. Med."},{"key":"2020071623201315600_CIT0028","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","article-title":"High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma","volume":"113","author":"Yoshikawa","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2020071623201315600_CIT0029","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"key":"2020071623201315600_CIT0030","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"Zack","year":"2013","journal-title":"Nat. Genet."},{"key":"2020071623201315600_CIT0031","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"van Haaften","year":"2009","journal-title":"Nat. Genet."},{"key":"2020071623201315600_CIT0032","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1083\/jcb.201611135","article-title":"Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair","volume":"216","author":"Gong","year":"2017","journal-title":"J. Cell Biol."},{"key":"2020071623201315600_CIT0033","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"2020071623201315600_CIT0034","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"2020071623201315600_CIT0035","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2020071623201315600_CIT0036","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"key":"2020071623201315600_CIT0037","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","article-title":"LATS2 is a tumor suppressor gene of malignant mesothelioma","volume":"71","author":"Murakami","year":"2011","journal-title":"Cancer Res."},{"key":"2020071623201315600_CIT0038","author":"COSMIC"},{"key":"2020071623201315600_CIT0039","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat. Genet."},{"key":"2020071623201315600_CIT0040","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/14737140.2016.1241149","article-title":"Immunotherapy for malignant mesothelioma: reality check","volume":"16","author":"Thapa","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"2020071623201315600_CIT0041","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/1471-2407-14-709","article-title":"Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions","volume":"14","author":"Szulkin","year":"2014","journal-title":"BMC Cancer"},{"key":"2020071623201315600_CIT0042","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2220\/biomedres.34.13","article-title":"Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma","volume":"34","author":"Goudarzi","year":"2013","journal-title":"Biomed. Res."},{"key":"2020071623201315600_CIT0043","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.99.13352799","article-title":"Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis","volume":"13","author":"Orengo","year":"1999","journal-title":"Eur. Respir. J."},{"key":"2020071623201315600_CIT0044","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910470219","article-title":"Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions","volume":"47","author":"Manning","year":"1991","journal-title":"Int. J. Cancer"},{"key":"2020071623201315600_CIT0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1073274816023004S01","article-title":"Best practices in treatment selection for patients with advanced NSCLC","volume":"23","author":"Socinski","year":"2016","journal-title":"Cancer Control"},{"key":"2020071623201315600_CIT0046","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.21037\/jtd.2016.03.17","article-title":"Tissue requirements in lung cancer diagnosis for tumor heterogeneity, mutational analysis and targeted therapies: initial experience with intra-operative Frozen Section Evaluation (FROSE) in bronchoscopic biopsies","volume":"8","author":"Iding","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"2020071623201315600_CIT0047","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1309\/AJCPMY8UI7WSFSYY","article-title":"Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas","volume":"143","author":"Schneider","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"2020071623201315600_CIT0048","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/annonc\/mdv208","article-title":"Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer","volume":"26","author":"Lim","year":"2015","journal-title":"Ann. Oncol."},{"key":"2020071623201315600_CIT0049","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cncy.21527","article-title":"FNA, core biopsy, or both for the diagnosis of lung carcinoma: obtaining sufficient tissue for a specific diagnosis and molecular testing","volume":"123","author":"Coley","year":"2015","journal-title":"Cancer Cytopathol."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/advance-article-pdf\/doi\/10.1093\/carcin\/bgz066\/28545792\/bgz066.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/6\/724\/28911783\/bgz066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/6\/724\/28911783\/bgz066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T01:53:40Z","timestamp":1721181220000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/40\/6\/724\/5479857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,25]]},"published-print":{"date-parts":[[2019,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgz066","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,4,25]]}}}